News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
A number of intranasal vaccines against COVID-19 are in development: hoping to provide a point of difference against authorized vaccines but also create a springboard for wider development against other respiratory diseases.
Multiple pharma R&D teams are seeking to transform how diabetes treatment is managed.
Lipid nanoparticle systems (LNPs) as a delivery mechanism for novel drug modalities are proving effective, but there are bioanalytical challenges associated with encapsulation, says an expert.
From wearable injectors to nasal inhalation devices, experts expect to see many developments in drug delivery as the biologics industry grows.